Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Lupus Erythematosus (CLE)”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableLooking for participantsNCT01510067
What this trial is testing

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
University of Pennsylvania 700
Testing effectiveness (Phase 2)Study completedNCT05162586
What this trial is testing

The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

Who this might be right for
Systemic Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 456
Early research (Phase 1)Looking for participantsNCT07749651
What this trial is testing

A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults

Who this might be right for
Cutaneous Lupus Erythematosus(CLE)
Guangdong Hengrui Pharmaceutical Co., Ltd 50
Not applicableLooking for participantsNCT06927219
What this trial is testing

Research Accelerated by You Lupus Registry

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Cutaneous Lupus Erythematosus (CLE)
Lupus Foundation of America 10,000
Testing effectiveness (Phase 2)Study completedNCT00317681
What this trial is testing

Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus
Heinrich-Heine University, Duesseldorf 30
Testing effectiveness (Phase 2)Study completedNCT03134222
What this trial is testing

Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus
Gilead Sciences 47
Not applicableStudy completedNCT00633945
What this trial is testing

Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
University of Pennsylvania 5
Not applicableStudy completedNCT01146444
What this trial is testing

Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)

Who this might be right for
Cutaneous Lupus Erythematosus
Spirig Pharma Ltd. 20
Not applicableUnknownNCT06411106
What this trial is testing

Deep Phenotyping of Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus
Centre for Human Drug Research, Netherlands 40
Testing effectiveness (Phase 2)Looking for participantsNCT07694336
What this trial is testing

Quinacrine in Participants With Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
Victoria Werth 24
Early research (Phase 1)Study completedNCT03817424
What this trial is testing

Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus ErythematosusSjogren's Syndrome+3 more
Amgen 31
Early research (Phase 1)Study completedNCT02927457
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects

Who this might be right for
Lupus Erythematosus, Cutaneous
GlaxoSmithKline 11
Testing effectiveness (Phase 2)Study completedNCT02847598
What this trial is testing

Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusActive Cutaneous Lupus Erythematosus
Biogen 264
Large-scale testing (Phase 3)Looking for participantsNCT07355218
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Who this might be right for
Systematic Lupus ErythematosusCutaneous Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 202
Early research (Phase 1)Active Not RecruitingNCT05411016
What this trial is testing

KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus

Who this might be right for
Healthy VolunteersSystemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
Kyowa Kirin Co., Ltd. 157
Testing effectiveness (Phase 2)Looking for participantsNCT07440537
What this trial is testing

Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
Beijing InnoCare Pharma Tech Co., Ltd. 105
Early research (Phase 1)Ended earlyNCT01470313
What this trial is testing

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus
Pfizer 28
Testing effectiveness (Phase 2)Ended earlyNCT05879718
What this trial is testing

Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus, Cutaneous
Pfizer 8
Large-scale testing (Phase 3)Not Yet RecruitingNCT06965244
What this trial is testing

Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
Assistance Publique - Hôpitaux de Paris 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT05540327
What this trial is testing

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Who this might be right for
Systemic Lupus Erythematosus
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 379
Next Page